Edition:
India

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

3.10USD
22 Jun 2018
Change (% chg)

$0.77 (+33.05%)
Prev Close
$2.33
Open
$3.40
Day's High
$3.60
Day's Low
$2.72
Volume
1,929,815
Avg. Vol
25,968
52-wk High
$3.70
52-wk Low
$1.35

Select another date:

Mon, Apr 2 2018

BRIEF-Soleno Therapeutics Reports Q4 Loss Per Share $0.43

* Q4 LOSS PER SHARE $0.39 FROM CONTINUING OPERATIONS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Soleno Therapeutics Announces Successful End-Of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES SUCCESSFUL END-OF-PHASE II MEETING WITH FDA FOR DCCR IN PRADER-WILLI SYNDROME

BRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln Shares

* SOLENO THERAPEUTICS INC FILES FOR RESALE OF UP TO 14.2 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (http://bit.ly/2DKTA0l) Further company coverage:

BRIEF-Jack W. Schuler Living Trust Reports 13.4 Pct Stake In Soleno Therapeutics As Of December 15

* JACK W. SCHULER LIVING TRUST REPORTS 13.4 PERCENT STAKE IN SOLENO THERAPEUTICS INC AS OF DECEMBER 15 - SEC FILING Source text: (http://bit.ly/2mkVVHQ) Further company coverage:

BRIEF-Soleno Therapeutics Says Board Resolved To Decrease Size Of Board From Ten To Seven

* SOLENO THERAPEUTICS SAYS ON JAN 2, BOARD RESOLVED TO DECREASE SIZE OF BOARD FROM TEN DIRECTORS TO SEVEN DIRECTORS - SEC FILING Source text for Eikon: (http://bit.ly/2F27EUa) Further company coverage:

BRIEF-Birchview Capital LP Reports A 6.17 Pct Passive Stake In Soleno Therapeutics

* BIRCHVIEW CAPITAL LP REPORTS A 6.17 PCT PASSIVE STAKE IN SOLENO THERAPEUTICS AS OF DEC 15 - SEC FILING Source text for Eikon: (http://bit.ly/2DT2Zn3) Further company coverage:

Select another date: